Publications:

---

Therapeutic Advances of Rare ALK Fusions in Non-Small Cell Lung Cancer.

Current Oncology (Toronto, Ont.)

Xiang, Yan Y; Zhang, Shiyu S; Fang, Xiaoxu X; Jiang, Yingying Y; Fang, Tingwen T; Liu, Jinwen J; Lu, Kaihua K

Publication Date: 2022-10-16

Variant appearance in text: ALK: L1152V

PubMed Link: 36290895

Variant Present in the following documents:

• Main text
• curroncol-29-00618.pdf

View BVdb publication page

---

Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective.

Signal Transduction And Targeted Therapy

Yang, Yang Y; Li, Shuo S; Wang, Yujiao Y; Zhao, Yi Y; Li, Qiu Q

Publication Date: 2022-09-17

Variant appearance in text: ALK: L1152V

PubMed Link: 36115852

Variant Present in the following documents:

• Main text
• 41392_2022_Article_1168.pdf

View BVdb publication page

---

Real-world insights into patients with advanced NSCLC and MET alterations.

Lung Cancer (Amsterdam, Netherlands)

Bittoni, Marisa M; Yang, James Chih-Hsin JC; Shih, Jin-Yuan JY; Peled, Nir N; Smit, Egbert F EF; Camidge, D Ross DR; Arasada, Rajeswara Rao RR; Oksen, Dina D; Boutmy, Emmanuelle E; Stroh, Christopher C; Johne, Andreas A; Carbone, David P DP; Paik, Paul K PK

Publication Date: 2021-09

Variant appearance in text: ALK: L1152V

PubMed Link: 34320421

Variant Present in the following documents:

• nihms-1819099.pdf

View BVdb publication page

---

[Pharmacology and Clinical Evaluation of Ensartinib Hydrochloride Capsule].

Zhongguo Fei Ai Za Zhi = Chinese Journal Of Lung Cancer

Wang, Yang Y; Yuan, Xiaobin X; Xiong, Jiayan J; Hao, Zhidong Z; Peng, Xingzhe X; Chen, Wanlin W; Cui, Lingling L; Li, Hua H; Wang, Xiulan X; He, Xiangbo X; Yang, Min M; Liang, Congxin C; Ma, Yongbin Y; Ding, Lieming L; Mao, Li L

Publication Date: 2020-08-20

Variant appearance in text: ALK: L1152V

PubMed Link: 32838492

Variant Present in the following documents:

• Main text
• zgfazz-23-8-719.pdf

View BVdb publication page

---

Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer.

Journal Of Thoracic Oncology : Official Publication Of The International Association For The Study Of Lung Cancer

Horn, Leora L; Whisenant, Jennifer G JG; Wakelee, Heather H; Reckamp, Karen L KL; Qiao, Huan H; Leal, Ticiana A TA; Du, Liping L; Hernandez, Jennifer J; Huang, Vincent V; Blumenschein, George R GR; Waqar, Saiama N SN; Patel, Sandip P SP; Nieva, Jorge J; Oxnard, Geoffrey R GR; Sanborn, Rachel E RE; Shaffer, Tristan T; Garg, Kavita K; Holzhausen, Allison A; Harrow, Kimberly K; Liang, Chris C; Lim, Lee P LP; Li, Mark M; Lovly, Christine M CM

Publication Date: 2019-11

Variant appearance in text: ALK: L1152V

PubMed Link: 31446141

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Crizotinib-resistant mutants of EML4-ALK identified through an accelerated mutagenesis screen.

Chemical Biology & Drug Design

Zhang, Sen S; Wang, Frank F; Keats, Jeffrey J; Zhu, Xiaotian X; Ning, Yaoyu Y; Wardwell, Scott D SD; Moran, Lauren L; Mohemmad, Qurish K QK; Anjum, Rana R; Wang, Yihan Y; Narasimhan, Narayana I NI; Dalgarno, David D; Shakespeare, William C WC; Miret, Juan J JJ; Clackson, Tim T; Rivera, Victor M VM

Publication Date: 2011-12

Variant appearance in text: ALK: L1152V

PubMed Link: 22034911

Variant Present in the following documents:

• Main text

View BVdb publication page

---